Your browser doesn't support javascript.
loading
Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.
Wang, Lihong; Arras, Janet; Katsha, Ahmed; Hamdan, Saif; Belkhiri, Abbes; Ecsedy, Jeffrey; El-Rifai, Wael.
Afiliação
  • Wang L; Department of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Arras J; Department of Veterans Affairs, Tennessee Valley Healthcare System, Nashville, TN, USA.
  • Katsha A; Department of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Hamdan S; Department of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Belkhiri A; Science and Engineering Department, Raritan Valley Community College, Branchburg, NJ, USA.
  • Ecsedy J; Department of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • El-Rifai W; Department of Surgery and Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, USA.
Mol Oncol ; 11(8): 981-995, 2017 08.
Article em En | MEDLINE | ID: mdl-28417568

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Azepinas / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Aurora Quinase A / Proteínas de Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Azepinas / Cisplatino / Resistencia a Medicamentos Antineoplásicos / Aurora Quinase A / Proteínas de Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article